Expression of regional brain amyloid-β deposition with ^[18F]Flutemetamol in Centiloid scale -a multi-site study

Zurück zum Zitat Jack C, Knopman D, Jagust W, Shaw L, Aisen P, Weiner M, Petersen R, Trojanowski J (2010) Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 9:119–128CrossRefPubMedPubMedCentral Jack C, Knopman D, Jagust W, Shaw L, Aisen P, Weiner M, Petersen R, Trojanowski J (2010) Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 9:119–128CrossRefPubMedPubMedCentral

Zurück zum Zitat Chételat G (2018) Multimodal neuroimaging in alzheimer’s disease: early diagnosis, physiopathological mechanisms, and impact of lifestyle. J Alzheimers Dis 64:S199-s211CrossRefPubMedPubMedCentral Chételat G (2018) Multimodal neuroimaging in alzheimer’s disease: early diagnosis, physiopathological mechanisms, and impact of lifestyle. J Alzheimers Dis 64:S199-s211CrossRefPubMedPubMedCentral

Zurück zum Zitat McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the national institute on aging-alzheimer’s association workgroups on diagnostic guidelines for alzheimer’s disease. Alzheimers Dement 7:263–269CrossRefPubMed McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the national institute on aging-alzheimer’s association workgroups on diagnostic guidelines for alzheimer’s disease. Alzheimers Dement 7:263–269CrossRefPubMed

Zurück zum Zitat Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of alzheimer’s disease: recommendations from the national institute on aging-alzheimer’s association workgroups on diagnostic guidelines for alzheimer’s disease. Alzheimers Dement 7:280–292CrossRefPubMed Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of alzheimer’s disease: recommendations from the national institute on aging-alzheimer’s association workgroups on diagnostic guidelines for alzheimer’s disease. Alzheimers Dement 7:280–292CrossRefPubMed

Zurück zum Zitat Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, Epelbaum S, Frisoni GB, Gauthier S, Genthon R, Gouw AA, Habert MO, Holtzman DM, Kivipelto M, Lista S, Molinuevo JL, O’Bryant SE, Rabinovici GD, Rowe C, Salloway S, Schneider LS, Sperling R, Teichmann M, Carrillo MC, Cummings J, Jack CR Jr (2016) Preclinical alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement 12:292–323CrossRefPubMed Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, Bakardjian H, Benali H, Bertram L, Blennow K, Broich K, Cavedo E, Crutch S, Dartigues JF, Duyckaerts C, Epelbaum S, Frisoni GB, Gauthier S, Genthon R, Gouw AA, Habert MO, Holtzman DM, Kivipelto M, Lista S, Molinuevo JL, O’Bryant SE, Rabinovici GD, Rowe C, Salloway S, Schneider LS, Sperling R, Teichmann M, Carrillo MC, Cummings J, Jack CR Jr (2016) Preclinical alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement 12:292–323CrossRefPubMed

Zurück zum Zitat Palmqvist S, Zetterberg H, Blennow K, Vestberg S, Andreasson U, Brooks DJ, Owenius R, Hägerström D, Wollmer P, Minthon L, Hansson O (2014) Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography. JAMA Neurol 71:1282–1289CrossRefPubMed Palmqvist S, Zetterberg H, Blennow K, Vestberg S, Andreasson U, Brooks DJ, Owenius R, Hägerström D, Wollmer P, Minthon L, Hansson O (2014) Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography. JAMA Neurol 71:1282–1289CrossRefPubMed

Zurück zum Zitat Ozlen H, Pichet Binette A, Köbe T, Meyer PF, Gonneaud J, St-Onge F, Provost K, Soucy JP, Rosa-Neto P, Breitner J, Poirier J, Villeneuve S (2022) Spatial extent of amyloid-β levels and associations with tau-pet and cognition. JAMA Neurol 79:1025–1035CrossRefPubMedPubMedCentral Ozlen H, Pichet Binette A, Köbe T, Meyer PF, Gonneaud J, St-Onge F, Provost K, Soucy JP, Rosa-Neto P, Breitner J, Poirier J, Villeneuve S (2022) Spatial extent of amyloid-β levels and associations with tau-pet and cognition. JAMA Neurol 79:1025–1035CrossRefPubMedPubMedCentral

Zurück zum Zitat Ishii K, Yamada T, Hanaoka K, Kaida H, Miyazaki K, Ueda M, Hanada K, Saigoh K, Sauerbeck J, Rominger A, Bartenstein P, Kimura Y (2020) Regional gray matter-dedicated SUVR with 3D-MRI detects positive amyloid deposits in equivocal amyloid PET images. Ann Nucl Med 34:856–863CrossRefPubMed Ishii K, Yamada T, Hanaoka K, Kaida H, Miyazaki K, Ueda M, Hanada K, Saigoh K, Sauerbeck J, Rominger A, Bartenstein P, Kimura Y (2020) Regional gray matter-dedicated SUVR with 3D-MRI detects positive amyloid deposits in equivocal amyloid PET images. Ann Nucl Med 34:856–863CrossRefPubMed

Zurück zum Zitat Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Jagust WJ, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, Rowe CC, Skovronsky DM, Mintun MA (2015) The centiloid project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement 11:1–15.e11–14. Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD, Jagust WJ, Johnson KA, Mathis CA, Minhas D, Pontecorvo MJ, Rowe CC, Skovronsky DM, Mintun MA (2015) The centiloid project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement 11:1–15.e11–14.

Zurück zum Zitat Battle MR, Pillay LC, Lowe VJ, Knopman D, Kemp B, Rowe CC, Doré V, Villemagne VL, Buckley CJ (2018) Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods. EJNMMI Res 8:107CrossRefPubMedPubMedCentral Battle MR, Pillay LC, Lowe VJ, Knopman D, Kemp B, Rowe CC, Doré V, Villemagne VL, Buckley CJ (2018) Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods. EJNMMI Res 8:107CrossRefPubMedPubMedCentral

Zurück zum Zitat Navitsky M, Joshi AD, Kennedy I, Klunk WE, Rowe CC, Wong DF, Pontecorvo MJ, Mintun MA, Devous MD Sr (2018) Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale. Alzheimers Dement 14:1565–1571CrossRefPubMed Navitsky M, Joshi AD, Kennedy I, Klunk WE, Rowe CC, Wong DF, Pontecorvo MJ, Mintun MA, Devous MD Sr (2018) Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale. Alzheimers Dement 14:1565–1571CrossRefPubMed

Zurück zum Zitat Rowe CC, Jones G, Doré V, Pejoska S, Margison L, Mulligan RS, Chan JG, Young K, Villemagne VL (2016) Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale. J Nucl Med 57:1233–1237CrossRefPubMed Rowe CC, Jones G, Doré V, Pejoska S, Margison L, Mulligan RS, Chan JG, Young K, Villemagne VL (2016) Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale. J Nucl Med 57:1233–1237CrossRefPubMed

Zurück zum Zitat Rowe CC, Doré V, Jones G, Baxendale D, Mulligan RS, Bullich S, Stephens AW, De Santi S, Masters CL, Dinkelborg L, Villemagne VL (2017) (18)F-Florbetaben PET beta-amyloid binding expressed in Centiloids. Eur J Nucl Med Mol Imaging 44:2053–2059CrossRefPubMedPubMedCentral Rowe CC, Doré V, Jones G, Baxendale D, Mulligan RS, Bullich S, Stephens AW, De Santi S, Masters CL, Dinkelborg L, Villemagne VL (2017) (18)F-Florbetaben PET beta-amyloid binding expressed in Centiloids. Eur J Nucl Med Mol Imaging 44:2053–2059CrossRefPubMedPubMedCentral

Zurück zum Zitat Amadoru S, Doré V, McLean CA, Hinton F, Shepherd CE, Halliday GM, Leyton CE, Yates PA, Hodges JR, Masters CL, Villemagne VL, Rowe CC (2020) Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease. Alzheimers Res Ther 12:22CrossRefPubMedPubMedCentral Amadoru S, Doré V, McLean CA, Hinton F, Shepherd CE, Halliday GM, Leyton CE, Yates PA, Hodges JR, Masters CL, Villemagne VL, Rowe CC (2020) Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease. Alzheimers Res Ther 12:22CrossRefPubMedPubMedCentral

Zurück zum Zitat Su Y, Flores S, Hornbeck RC, Speidel B, Vlassenko AG, Gordon BA, Koeppe RA, Klunk WE, Xiong C, Morris JC, Benzinger TLS (2018) Utilizing the centiloid scale in cross-sectional and longitudinal PiB PET studies. Neuroimage Clin 19:406–416CrossRefPubMedPubMedCentral Su Y, Flores S, Hornbeck RC, Speidel B, Vlassenko AG, Gordon BA, Koeppe RA, Klunk WE, Xiong C, Morris JC, Benzinger TLS (2018) Utilizing the centiloid scale in cross-sectional and longitudinal PiB PET studies. Neuroimage Clin 19:406–416CrossRefPubMedPubMedCentral

Zurück zum Zitat Hanseeuw BJ, Malotaux V, Dricot L, Quenon L, Sznajer Y, Cerman J, Woodard JL, Buckley C, Farrar G, Ivanoiu A, Lhommel R (2021) Defining a centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18 F] flutemetamol amyloid PET study. Eur J Nucl Med Mol Imaging 48:302–310CrossRefPubMed Hanseeuw BJ, Malotaux V, Dricot L, Quenon L, Sznajer Y, Cerman J, Woodard JL, Buckley C, Farrar G, Ivanoiu A, Lhommel R (2021) Defining a centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18 F] flutemetamol amyloid PET study. Eur J Nucl Med Mol Imaging 48:302–310CrossRefPubMed

Zurück zum Zitat Nelissen N, Van Laere K, Thurfjell L, Owenius R, Vandenbulcke M, Koole M, Bormans G, Brooks D, Vandenberghe R (2009) Phase 1 study of the pittsburgh compound b derivative ^sup 18^F-flutemetamol in healthy volunteers and patients with probable alzheimer disease. J Nucl Med 50:1251–1259CrossRefPubMed Nelissen N, Van Laere K, Thurfjell L, Owenius R, Vandenbulcke M, Koole M, Bormans G, Brooks D, Vandenberghe R (2009) Phase 1 study of the pittsburgh compound b derivative ^sup 18^F-flutemetamol in healthy volunteers and patients with probable alzheimer disease. J Nucl Med 50:1251–1259CrossRefPubMed

Zurück zum Zitat Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, Hasselbalch S, Law I, Andersen A, Korner A, Minthon L, Garraux G, Nelissen N, Bormans G, Buckley C, Owenius R, Thurfjell L, Farrar G, Brooks DJ (2010) 18F-flutemetamol amyloid imaging in alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol 68:319–329CrossRefPubMed Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E, Bastin C, Triau E, Hasselbalch S, Law I, Andersen A, Korner A, Minthon L, Garraux G, Nelissen N, Bormans G, Buckley C, Owenius R, Thurfjell L, Farrar G, Brooks DJ (2010) 18F-flutemetamol amyloid imaging in alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol 68:319–329CrossRefPubMed

Zurück zum Zitat Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19:1233–1239CrossRefPubMed Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19:1233–1239CrossRefPubMed

Zurück zum Zitat Palmqvist S, Schöll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, Blennow K, Landau S, Jagust W, Hansson O (2017) Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun 8:1214CrossRefPubMedPubMedCentral Palmqvist S, Schöll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, Blennow K, Landau S, Jagust W, Hansson O (2017) Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun 8:1214CrossRefPubMedPubMedCentral

Zurück zum Zitat Grothe JM, Barthel JH, Sepulcre JJ, Dyrba JM, Sabri JO, Teipel JS (2017) In vivo staging of regional amyloid deposition. Neurology 89:2031–2038CrossRefPubMedPubMedCentral Grothe JM, Barthel JH, Sepulcre JJ, Dyrba JM, Sabri JO, Teipel JS (2017) In vivo staging of regional amyloid deposition. Neurology 89:2031–2038CrossRefPubMedPubMedCentral

Zurück zum Zitat Song X-W, Dong Z-Y, Long X-Y, Li S-F, Zuo X-N, Zhu C-Z, He Y, Yan C-G, Zang Y-F (2011) REST: A Toolkit for Resting-State Functional Magnetic Resonance Imaging Data Processing. PLoS ONE 6:e25031CrossRefPubMedPubMedCentral Song X-W, Dong Z-Y, Long X-Y, Li S-F, Zuo X-N, Zhu C-Z, He Y, Yan C-G, Zang Y-F (2011) REST: A Toolkit for Resting-State Functional Magnetic Resonance Imaging Data Processing. PLoS ONE 6:e25031CrossRefPubMedPubMedCentral

Zurück zum Zitat Flutemetamol F 18 Injection, GE Healthcare. https://www.gehealthcare.co.uk/-/jssmedia/widen/gehealthcarecom/migrated/er-clinical-product-info-vizamyl-203-8c17d992a0aa9aadb2e446d7f5580a8b_43-1067c_vizamyl_pdf.pdf?rev=f0b80c4c7a0440ebaf7fb2f92883cfbb&hash=6C5B978AB8A1A17937F3FB8A3733687A, Flutemetamol F 18 Injection, GE Healthcare. https://​www.​gehealthcare.​co.​uk/​-/​jssmedia/​widen/​gehealthcarecom/​migrated/​er-clinical-product-info-vizamyl-203-8c17d992a0aa9aad​b2e446d7f5580a8b​_​43-1067c_​vizamyl_​pdf.​pdf?​rev=​f0b80c4c7a0440eb​af7fb2f92883cfbb​&​hash=​6C5B978AB8A1A179​37F3FB8A3733687A​,

Zurück zum Zitat Tudorascu DL, Minhas DS, Lao PJ, Betthauser TJ, Yu Z, Laymon CM, Lopresti BJ, Mathis CA, Klunk WE, Handen BL, Christian BT, Cohen AD (2018) The use of Centiloids for applying [11C]PiB classification cutoffs across region-of-interest delineation methods. Alzheimers Dement 10:332–339 Tudorascu DL, Minhas DS, Lao PJ, Betthauser TJ, Yu Z, Laymon CM, Lopresti BJ, Mathis CA, Klunk WE, Handen BL, Christian BT, Cohen AD (2018) The use of Centiloids for applying [11C]PiB classification cutoffs across region-of-interest delineation methods. Alzheimers Dement 10:332–339

Zurück zum Zitat Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B (2016) A/T/N: An unbiased descriptive classification scheme for alzheimer disease biomarkers. Neurology 87:539–547CrossRefPubMedPubMedCentral Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS, Petersen RC, Scheltens P, Sperling RA, Dubois B (2016) A/T/N: An unbiased descriptive classification scheme for alzheimer disease biomarkers. Neurology 87:539–547CrossRefPubMedPubMedCentral

Zurück zum Zitat Cho H, Choi JY, Hwang MS, Kim YJ, Lee HM, Lee HS, Lee JH, Ryu YH, Lee MS, Lyoo CH (2016) In vivo cortical spreading pattern of tau and amyloid in the alzheimer disease spectrum. Ann Neurol 80:247–258CrossRefPubMed Cho H, Choi JY, Hwang MS, Kim YJ, Lee HM, Lee HS, Lee JH, Ryu YH, Lee MS, Lyoo CH (2016) In vivo cortical spreading pattern of tau and amyloid in the alzheimer disease spectrum. Ann Neurol 80:247–258CrossRefPubMed

Zurück zum Zitat Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800CrossRefPubMed Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800CrossRefPubMed

Zurück zum Zitat Wang P, Chen K, Yao L, Hu B, Wu X, Zhang J, Ye Q, Guo X (2016) Multimodal classification of mild cognitive impairment based on partial least squares. J Alzheimer’s Dis: JAD 54:359–371CrossRefPubMed Wang P, Chen K, Yao L, Hu B, Wu X, Zhang J, Ye Q, Guo X (2016) Multimodal classification of mild cognitive impairment based on partial least squares. J Alzheimer’s Dis: JAD 54:359–371CrossRefPubMed

Zurück zum Zitat Bao YW, Chau ACM, Chiu PK, Shea YF, Kwan JSK, Chan FHW, Mak HK (2021) Heterogeneity of amyloid binding in cognitively impaired patients consecutively recruited from a memory clinic: evaluating the utility of quantitative 18F-Flutemetamol PET-CT in discrimination of mild cognitive impairment from alzheimer’s disease and other dementias. J Alzheimers Dis 79:819–832CrossRefPubMedPubMedCentral Bao YW, Chau ACM, Chiu PK, Shea YF, Kwan JSK, Chan FHW, Mak HK (2021) Heterogeneity of amyloid binding in cognitively impaired patients consecutively recruited from a memory clinic: evaluating the utility of quantitative 18F-Flutemetamol PET-CT in discrimination of mild cognitive impairment from alzheimer’s disease and other dementias. J Alzheimers Dis 79:819–832CrossRefPubMedPubMedCentral

Zurück zum Zitat Royse SK, Minhas DS, Lopresti BJ, Murphy A, Ward T, Koeppe RA, Bullich S, DeSanti S, Jagust WJ, Landau SM (2021) Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach. Alzheimer’s Res Ther 13:99–99CrossRef Royse SK, Minhas DS, Lopresti BJ, Murphy A, Ward T, Koeppe RA, Bullich S, DeSanti S, Jagust WJ, Landau SM (2021) Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach. Alzheimer’s Res Ther 13:99–99CrossRef

Zurück zum Zitat Doré V, Bullich S, Rowe CC, Bourgeat P, Konate S, Sabri O, Stephens AW, Barthel H, Fripp J, Masters CL, Dinkelborg L, Salvado O, Villemagne VL, De Santi S (2019) Comparison of (18)F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL(®) approaches: validation against histopathology. Alzheimers Dement 15:807–816CrossRefPubMed Doré V, Bullich S, Rowe CC, Bourgeat P, Konate S, Sabri O, Stephens AW, Barthel H, Fripp J, Masters CL, Dinkelborg L, Salvado O, Villemagne VL, De Santi S (2019) Comparison of (18)F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL(®) approaches: validation against histopathology. Alzheimers Dement 15:807–816CrossRefPubMed

Zurück zum Zitat La Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, Doré V, Grinberg LT, Huang E, Hwang JH, Ikonomovic MD, Jack C Jr, Jagust WJ, Jin LW, Klunk WE, Kofler J, Lesman-Segev OH, Lockhart SN, Lowe VJ, Masters CL, Mathis CA, McLean CL, Miller BL, Mungas D, O’Neil JP, Olichney JM, Parisi JE, Petersen RC, Rosen HJ, Rowe CC, Spina S, Vemuri P, Villemagne VL, Murray ME, Rabinovici GD (2019) Multisite study of the relationships between antemortem [(11)C]PIB-PET Centiloid values and postmortem measures of Alzheimer’s disease neuropathology. Alzheimers Dement 15:205–216CrossRefPubMed La Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, Doré V, Grinberg LT, Huang E, Hwang JH, Ikonomovic MD, Jack C Jr, Jagust WJ, Jin LW, Klunk WE, Kofler J, Lesman-Segev OH, Lockhart SN, Lowe VJ, Masters CL, Mathis CA, McLean CL, Miller BL, Mungas D, O’Neil JP, Olichney JM, Parisi JE, Petersen RC, Rosen HJ, Rowe CC, Spina S, Vemuri P, Villemagne VL, Murray ME, Rabinovici GD (2019) Multisite study of the relationships between antemortem [(11)C]PIB-PET Centiloid values and postmortem measures of Alzheimer’s disease neuropathology. Alzheimers Dement 15:205–216CrossRefPubMed

Zurück zum Zitat Rodrigue KM, Kennedy KM, Devous MD Sr, Rieck JR, Hebrank AC, Diaz-Arrastia R, Mathews D, Park DC (2012) β-Amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology 78:387–395CrossRefPubMedPubMedCentral Rodrigue KM, Kennedy KM, Devous MD Sr, Rieck JR, Hebrank AC, Diaz-Arrastia R, Mathews D, Park DC (2012) β-Amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology 78:387–395CrossRefPubMedPubMedCentral

Zurück zum Zitat Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66:1837–1844CrossRefPubMed Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66:1837–1844CrossRefPubMed

Zurück zum Zitat Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FRJ, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Bibeau K, Blennow K, Brooks DJ, van Buchem MA, Camus V, Cavedo E, Chen K, Chetelat G, Cohen AD, Drzezga A, Engelborghs S, Fagan AM, Fladby T, Fleisher AS, van der Flier WM, Ford L, Förster S, Fortea J, Foskett N, Frederiksen KS, Freund-Levi Y, Frisoni GB, Froelich L, Gabryelewicz T, Gill KD, Gkatzima O, Gómez-Tortosa E, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka S-K, Hildebrandt H, Ishihara L, Ivanoiu A, Jagust WJ, Johannsen P, Kandimalla R, Kapaki E, Klimkowicz-Mrowiec A, Klunk WE, Köhler S, Koglin N, Kornhuber J, Kramberger MG, Van Laere K, Landau SM, Lee DY, de Leon M, Lisetti V, Lleó A, Madsen K, Maier W, Marcusson J, Mattsson N, de Mendonça A, Meulenbroek O, Meyer PT, Mintun MA, Mok V, Molinuevo JL, Møllergård HM, Morris JC, Mroczko B, Van der Mussele S, Na DL, Newberg A, Nordberg A, Nordlund A, Novak GP, Paraskevas GP, Parnetti L, Perera G, Peters O, Popp J, Prabhakar S, Rabinovici GD, Ramakers IHGB, Rami L, Resende de Oliveira C, Rinne JO, Rodrigue KM, Rodríguez-Rodríguez E, Roe CM, Rot U, Rowe CC, Rüther E, Sabri O, Sanchez-Juan P, Santana I, Sarazin M, Schröder J, Schütte C, Seo SW, Soetewey F, Soininen H, Spiru L, Struyfs H, Teunissen CE, Tsolaki M, Vandenberghe R, Verbeek MM, Villemagne VL, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin A, Wallin Å, Wiltfang J, Wolk DA, Zboch M, Zetterberg H (2015) Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA 313:1924–1938 Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FRJ, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Bibeau K, Blennow K, Brooks DJ, van Buchem MA, Camus V, Cavedo E, Chen K, Chetelat G, Cohen AD, Drzezga A, Engelborghs S, Fagan AM, Fladby T, Fleisher AS, van der Flier WM, Ford L, Förster S, Fortea J, Foskett N, Frederiksen KS, Freund-Levi Y, Frisoni GB, Froelich L, Gabryelewicz T, Gill KD, Gkatzima O, Gómez-Tortosa E, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka S-K, Hildebrandt H, Ishihara L, Ivanoiu A, Jagust WJ, Johannsen P, Kandimalla R, Kapaki E, Klimkowicz-Mrowiec A, Klunk WE, Köhler S, Koglin N, Kornhuber J, Kramberger MG, Van Laere K, Landau SM, Lee DY, de Leon M, Lisetti V, Lleó A, Madsen K, Maier W, Marcusson J, Mattsson N, de Mendonça A, Meulenbroek O, Meyer PT, Mintun MA, Mok V, Molinuevo JL, Møllergård HM, Morris JC, Mroczko B, Van der Mussele S, Na DL, Newberg A, Nordberg A, Nordlund A, Novak GP, Paraskevas GP, Parnetti L, Perera G, Peters O, Popp J, Prabhakar S, Rabinovici GD, Ramakers IHGB, Rami L, Resende de Oliveira C, Rinne JO, Rodrigue KM, Rodríguez-Rodríguez E, Roe CM, Rot U, Rowe CC, Rüther E, Sabri O, Sanchez-Juan P, Santana I, Sarazin M, Schröder J, Schütte C, Seo SW, Soetewey F, Soininen H, Spiru L, Struyfs H, Teunissen CE, Tsolaki M, Vandenberghe R, Verbeek MM, Villemagne VL, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin A, Wallin Å, Wiltfang J, Wolk DA, Zboch M, Zetterberg H (2015) Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA 313:1924–1938

Zurück zum Zitat Albrecht MA, Szoeke C, Maruff P, Savage G, Lautenschlager NT, Ellis KA, Taddei K, Martins R, Masters CL, Ames D, Foster JK (2015) Longitudinal cognitive decline in the AIBL cohort: the role of APOE ε4 status. Neuropsychologia 75:411–419CrossRefPubMed Albrecht MA, Szoeke C, Maruff P, Savage G, Lautenschlager NT, Ellis KA, Taddei K, Martins R, Masters CL, Ames D, Foster JK (2015) Longitudinal cognitive decline in the AIBL cohort: the role of APOE ε4 status. Neuropsychologia 75:411–419CrossRefPubMed

Zurück zum Zitat Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, La Joie R, Arthur-Bentil SK, Vogel JW, Marks SM, Lehmann M, Rosen HJ, Reed B, Olichney J, Boxer AL, Miller BL, Borys E, Jin LW, Huang EJ, Grinberg LT, DeCarli C, Seeley WW, Jagust W (2015) Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain 138:2020–2033CrossRefPubMedPubMedCentral Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, La Joie R, Arthur-Bentil SK, Vogel JW, Marks SM, Lehmann M, Rosen HJ, Reed B, Olichney J, Boxer AL, Miller BL, Borys E, Jin LW, Huang EJ, Grinberg LT, DeCarli C, Seeley WW, Jagust W (2015) Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain 138:2020–2033CrossRefPubMedPubMedCentral

Zurück zum Zitat Mesulam MM, Rogalski EJ, Wieneke C, Hurley RS, Geula C, Bigio EH, Thompson CK, Weintraub S (2014) Primary progressive aphasia and the evolving neurology of the language network. Nat Rev Neurol 10:554–569CrossRefPubMedPubMedCentral Mesulam MM, Rogalski EJ, Wieneke C, Hurley RS, Geula C, Bigio EH, Thompson CK, Weintraub S (2014) Primary progressive aphasia and the evolving neurology of the language network. Nat Rev Neurol 10:554–569CrossRefPubMedPubMedCentral